Satoshi Tada

1.0k total citations
38 papers, 456 citations indexed

About

Satoshi Tada is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Satoshi Tada has authored 38 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 11 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Satoshi Tada's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Satoshi Tada is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Satoshi Tada collaborates with scholars based in Japan and United States. Satoshi Tada's co-authors include Masahiro Nagai, Rina Ando, Hayato Yabe, Toshihiko Ishida, Koji Murao, Koichi Yamaguchi, Hitomi Imachi, Yuki Yamanishi, Tomohiko Taminato and Masahiro Nomoto and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Satoshi Tada

36 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Tada Japan 12 154 147 122 98 78 38 456
Ping Cai China 12 114 0.7× 83 0.6× 112 0.9× 98 1.0× 175 2.2× 34 614
Piotr Radojewski Switzerland 13 293 1.9× 200 1.4× 211 1.7× 100 1.0× 87 1.1× 41 524
Pei‐Wen Zhu China 17 75 0.5× 42 0.3× 54 0.4× 84 0.9× 56 0.7× 54 661
Lance T. Hall United States 15 46 0.3× 79 0.5× 113 0.9× 55 0.6× 68 0.9× 34 624
G. Gatti Italy 17 387 2.5× 418 2.8× 248 2.0× 90 0.9× 127 1.6× 44 884
Roberto Pariente Spain 6 288 1.9× 263 1.8× 133 1.1× 204 2.1× 88 1.1× 10 722
Jincao Chen China 13 51 0.3× 73 0.5× 225 1.8× 80 0.8× 41 0.5× 56 503
Shalom Michowiz Israel 14 128 0.8× 52 0.4× 160 1.3× 123 1.3× 150 1.9× 44 705
Hyo Joon Kim South Korea 12 116 0.8× 59 0.4× 39 0.3× 223 2.3× 28 0.4× 49 481
Bence Nagy Austria 14 109 0.7× 96 0.7× 52 0.4× 134 1.4× 50 0.6× 36 501

Countries citing papers authored by Satoshi Tada

Since Specialization
Citations

This map shows the geographic impact of Satoshi Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Tada more than expected).

Fields of papers citing papers by Satoshi Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Tada. The network helps show where Satoshi Tada may publish in the future.

Co-authorship network of co-authors of Satoshi Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Tada. A scholar is included among the top collaborators of Satoshi Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Tada. Satoshi Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tada, Satoshi, et al.. (2025). Fluorescent nucleobase analogue for cellular visualisation and regulation of immunostimulatory CpG oligodeoxynucleotides. Organic & Biomolecular Chemistry. 23(15). 3535–3541. 1 indexed citations
2.
Ito, Yuko, Yuki Yamanishi, Satoshi Tada, et al.. (2024). Optimization of oral entacapone administration in patients undergoing levodopa–carbidopa intestinal gel treatment. Journal of the Neurological Sciences. 457. 122901–122901. 1 indexed citations
3.
Nagai, Masahiro, et al.. (2023). Differing Patterns of Diurnal Variation and Impact of Antacids on Levodopa Pharmacokinetics in Patients with Parkinson's Disease. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 54(1). 3–8. 1 indexed citations
4.
Ohara, Kazuaki, et al.. (2023). A spectrophotometric method for the determination of tryptophan following oxidation by the addition of sodium hypochlorite pentahydrate. PLoS ONE. 18(1). e0279547–e0279547. 7 indexed citations
5.
Tokuhara, Yasunori, et al.. (2023). Detection of homogentisic acid by electrospray ionization mass spectrometry. Journal of Clinical Laboratory Analysis. 37(21-22). e24976–e24976. 2 indexed citations
6.
Hosokawa, Yuko, et al.. (2022). Clinical use of CSF neopterin levels in CNS demyelinating diseases. Journal of the Neurological Sciences. 441. 120385–120385. 5 indexed citations
7.
Hosokawa, Yuko, Akira Yoshida, Yuki Yamanishi, et al.. (2021). Fasting state is one of the factors associated with plasma levodopa fluctuations during levodopa‒carbidopa intestinal gel treatment. Parkinsonism & Related Disorders. 91. 55–58. 6 indexed citations
8.
Yabe, Hayato, et al.. (2020). Relapse of neuromyelitis optica with occipital neuralgia and elevated CSF neopterin. Neurology and Clinical Neuroscience. 8(4). 209–211. 2 indexed citations
9.
Yabe, Hayato, et al.. (2020). Three cases of rheumatoid meningitis with elevated CSF neopterin levels. Journal of Neuroimmunology. 348. 577396–577396. 6 indexed citations
10.
Iwaki, Hirotaka, Rina Ando, Satoshi Tada, et al.. (2020). A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease. Journal of the Neurological Sciences. 414. 116833–116833. 14 indexed citations
11.
Yamanishi, Yuki, Satoshi Tada, Rina Ando, et al.. (2019). A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion. Multiple Sclerosis and Related Disorders. 31. 62–64. 11 indexed citations
12.
Yamanishi, Yuki, et al.. (2019). Acromioclavicular joint arthritis as the first manifestation of Austrian syndrome. Journal of Infection and Chemotherapy. 26(1). 124–127. 1 indexed citations
13.
Yamanishi, Yuki, Satoshi Tada, Rina Ando, et al.. (2019). Repetitive brainstem lesions in mitochondrial DNA 11778G>A mutation of Leber hereditary optic neuropathy. eNeurologicalSci. 14. 74–76. 2 indexed citations
14.
Tada, Satoshi, Rina Ando, Hirotaka Iwaki, et al.. (2017). DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism. Parkinsonism & Related Disorders. 44. 137–141. 6 indexed citations
15.
Iwaki, Hirotaka, Rina Ando, Satoshi Tada, et al.. (2017). One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan. Journal of the Neurological Sciences. 383. 75–78. 21 indexed citations
16.
Miyoshi, Tomohiro, Shigeki Umemura, Yuki Matsumura, et al.. (2016). Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical Cancer Research. 23(3). 757–765. 139 indexed citations
17.
Inamura, Naoko, Toshiya Kimura, Satoshi Tada, et al.. (2012). Intrinsic and Extrinsic Mechanisms Control the Termination of Cortical Interneuron Migration. Journal of Neuroscience. 32(17). 6032–6042. 29 indexed citations
18.
Tada, Satoshi, et al.. (2010). Reactivity of rare sugar D-allose during glycation of human serum albumin. 33(3). 227–236. 2 indexed citations
19.
Murao, Koji, Hitomi Imachi, Hisashi Masugata, et al.. (2009). Exendin-4 regulates pancreatic ABCA1 transcription via CaMKK/CaMKIV pathway. Journal of Cellular and Molecular Medicine. 20 indexed citations
20.
Tada, Satoshi, et al.. (1998). Automated Fluorimetric Determination of Cellular Cholesterol. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 35(5). 665–670. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026